Medicare Enrolled
Dr. Thomas Lanchoney, MD
Urology Physician · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lanchoney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lanchoney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lanchoney
Dr. Thomas Lanchoney is an urology physician in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lanchoney performed 9,403 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lanchoney received a total of $7,813 from 47 pharmaceutical and/or device companies across 307 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lanchoney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in PA
$7,813 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,403
Medicare services
Top 3% in PA for urology physician
Not available
Unique patients (not deduplicated)
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
3,100 | $5 | $9 |
| BCG treatment for bladder cancer | 1,300 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,164 | $3 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
867 | $95 | $294 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
645 | $67 | $210 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
457 | $8 | $68 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
305 | $51 | $86 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
221 | $66 | $117 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
196 | $121 | $358 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
180 | $63 | $600 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
160 | $2 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 159 | $123 | $800 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
138 | $8 | $12 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
77 | $109 | $215 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
68 | $26 | $100 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
41 | $42 | $498 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
37 | $103 | $455 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
37 | $25 | $250 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
26 | $73 | $215 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
25 | $119 | $507 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
22 | $141 | $550 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $151 | $472 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $111 | $1,029 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
16 | $29 | $437 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
16 | $167 | $366 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
15 | $304 | $817 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $340 | $785 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
15 | $583 | $1,235 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
14 | $66 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $146 | $316 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $48 | $75 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
12 | $6 | $188 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
12 | $174 | $701 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.8% high complexity
39.3% medium
59.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,813
Total received (2018-2024)
Avg $1,116/year across 7 years
Top 18% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
307
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$851
2023
$908
2022
$845
2021
$918
2020
$976
2019
$1,480
2018
$1,836
Payments by company (2024)
Axonics, Inc.
$241
Dendreon Pharmaceuticals LLC
$216
ABBVIE INC.
$194
Medtronic, Inc.
$44
Sumitomo Pharma America, Inc.
$40
PROCEPT BioRobotics Corporation
$38
Novartis Pharmaceuticals Corporation
$33
Janssen Biotech, Inc.
$29
BIOPROTECT MEDICAL, INC.
$16
Top 3 companies account for 76.5% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,287
Dendreon Pharmaceuticals LLC
$966
Axonics, Inc.
$742
Janssen Biotech, Inc.
$563
Teleflex LLC
$452
Bayer HealthCare Pharmaceuticals Inc.
$437
NeoTract Inc.
$386
ABBVIE INC.
$365
Allergan, Inc.
$247
Ferring Pharmaceuticals Inc.
$244
PFIZER INC.
$226
Merck Sharp & Dohme Corporation
$200
Avadel Specialty Pharmaceuticals, LLC
$138
MEDIVATION FIELD SOLUTIONS LLC
$119
AbbVie, Inc.
$116
Acerus Pharmaceuticals Corporation
$110
UROGEN PHARMA, INC.
$101
TOLMAR Pharmaceuticals, Inc.
$78
Coloplast Corp
$77
Myriad Genetic Laboratories, Inc.
$73
Medtronic, Inc.
$71
UROVANT SCIENCES INC
$62
Aytu BioScience, Inc
$61
Allergan Inc.
$58
Boston Scientific Corporation
$44
Amgen Inc.
$43
CooperSurgical, Inc.
$41
Sumitomo Pharma America, Inc.
$40
Blue Earth Diagnostics Limited
$40
PROCEPT BioRobotics Corporation
$38
Alnylam Pharmaceuticals Inc.
$33
Novartis Pharmaceuticals Corporation
$33
Antares Pharma, Inc.
$32
Mission Pharmacal Company
$27
Curium US LLC
$26
Axonics Modulation Technologies, Inc.
$25
Endo Pharmaceuticals Inc.
$25
Olympus America Inc.
$24
ACCORD HEALTHCARE, INC.
$23
Merck Sharp & Dohme LLC
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Progenics Pharmaceuticals, Inc.
$20
AbbVie Inc.
$18
180 Medical, Inc.
$18
Foundation Medicine, Inc.
$17
BIOPROTECT MEDICAL, INC.
$16
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Bulkamid · CAMCEVI · CONTINENCE CARE · ELIGARD · ERLEADA · Endosee · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL THERAPIES · GENTLECATH · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · PENILE & TESTICULAR RECONSTRUCTN · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Rezum Generator · SPEEDICATH · SUTENT · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
306
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lanchoney is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lanchoney experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Lanchoney performed 3,100 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lanchoney receive payments from pharmaceutical companies?
Yes. Dr. Lanchoney received a total of $7,813 from 47 companies across 307 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lanchoney's costs compare to other urology physicians in Bryn Mawr?
Dr. Lanchoney's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lanchoney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bryn Mawr
Browse urology physicians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology